<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>patient engagement in mental health &#8211; Science</title>
	<atom:link href="https://scienmag.com/tag/patient-engagement-in-mental-health/feed/" rel="self" type="application/rss+xml" />
	<link>https://scienmag.com</link>
	<description></description>
	<lastBuildDate>Thu, 09 Oct 2025 19:10:13 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://scienmag.com/wp-content/uploads/2024/07/cropped-scienmag_ico-32x32.jpg</url>
	<title>patient engagement in mental health &#8211; Science</title>
	<link>https://scienmag.com</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">73899611</site>	<item>
		<title>Rapid OCD Recovery: Inside Bergen’s 4-Day Treatment</title>
		<link>https://scienmag.com/rapid-ocd-recovery-inside-bergens-4-day-treatment/</link>
		
		<dc:creator><![CDATA[SCIENMAG]]></dc:creator>
		<pubDate>Thu, 09 Oct 2025 19:10:13 +0000</pubDate>
				<category><![CDATA[Psychology & Psychiatry]]></category>
		<category><![CDATA[adherence in OCD therapy]]></category>
		<category><![CDATA[Bergen 4-day treatment]]></category>
		<category><![CDATA[chronic mental health conditions]]></category>
		<category><![CDATA[cognitive-behavioral techniques for OCD]]></category>
		<category><![CDATA[innovative OCD therapies]]></category>
		<category><![CDATA[intensive exposure and response prevention therapy]]></category>
		<category><![CDATA[obsessive-compulsive disorder treatment]]></category>
		<category><![CDATA[outcomes of OCD treatment]]></category>
		<category><![CDATA[patient engagement in mental health]]></category>
		<category><![CDATA[rapid OCD recovery]]></category>
		<category><![CDATA[short-term therapy for OCD]]></category>
		<category><![CDATA[treatment motivation in OCD]]></category>
		<guid isPermaLink="false">https://scienmag.com/rapid-ocd-recovery-inside-bergens-4-day-treatment/</guid>

					<description><![CDATA[In a groundbreaking study published in BMC Psychiatry, researchers have shed new light on the intricate relationship between treatment motivation, adherence, and outcomes in patients battling difficult-to-treat obsessive–compulsive disorder (OCD). The investigation, centered around the innovative Bergen 4-day treatment program, challenges long-held assumptions about the predictive power of pre-treatment motivation measurements and underscores the critical [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>In a groundbreaking study published in <em>BMC Psychiatry</em>, researchers have shed new light on the intricate relationship between treatment motivation, adherence, and outcomes in patients battling difficult-to-treat obsessive–compulsive disorder (OCD). The investigation, centered around the innovative Bergen 4-day treatment program, challenges long-held assumptions about the predictive power of pre-treatment motivation measurements and underscores the critical role of patient engagement during therapy.</p>
<p>Obsessive–compulsive disorder is a chronic and debilitating mental health condition, characterized by intrusive thoughts and compulsive behaviors that significantly impair daily functioning. Despite the availability of evidence-based treatments, a subset of patients remain resistant or experience relapse, prompting a deeper exploration into factors that may influence therapeutic success. This new study zeroes in on the motivational dynamics that could make or break the effectiveness of intensive exposure and response prevention (EX/RP) therapy delivered in a condensed four-day format.</p>
<p>The Bergen 4-day treatment is designed to provide a concentrated therapeutic experience, incorporating cognitive-behavioral techniques tailored for rapid symptom reduction. The uniqueness of this approach lies not only in its brevity but also in its capacity to engage patients intensely over a short period, making motivation and adherence particularly pivotal elements. Researchers enlisted 163 outpatients who had previously relapsed or shown inadequate responses to standard interventions, ensuring a focus on a challenging clinical population.</p>
<p>Prior to the initiation of treatment, participants’ motivation was assessed using a modified version of the Nijmegen Motivational List 2 (NML2), a tool commonly employed to gauge commitment levels towards therapeutic protocols. This baseline measurement aimed to determine if initial motivation could serve as a reliable predictor of treatment success. However, the study&#8217;s findings suggest a more nuanced reality. While some motivation items related to commitment exhibited a modest correlation with positive outcomes, their predictive strength diminished significantly when factoring in patient adherence during the treatment itself.</p>
<p>Adherence was tracked in real-time using the Patient Exposure and Response Prevention (EX/RP) Adherence Scale (PEAS), which patients completed to rate their compliance with therapeutic exercises throughout the treatment sessions. This dynamic measure illuminated the importance of ongoing engagement rather than static pre-treatment motivation scores. In fact, adherence during both in- and between-session activities demonstrated a robust correlation with symptom improvement, as measured by the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) at treatment conclusion and at the three-month follow-up.</p>
<p>These findings underscore a critical distinction in the motivation-adherence paradigm. Pre-treatment motivation, often considered a foundation for success, shows limited standalone predictive power. Instead, the act of sustained patient adherence—reflecting the multifaceted concept of treatment engagement—emerges as a more potent driver of recovery. This insight invites a paradigm shift in both clinical assessment and therapeutic strategy, where fostering and monitoring adherence may take precedence over merely evaluating initial patient motivation.</p>
<p>Clinicians working with OCD patients might take invaluable cues from this study. It suggests that building mechanisms to support continuous engagement during the treatment process could be far more beneficial than relying on preliminary motivation screenings. Such mechanisms might include structured support systems, real-time feedback, and adaptive interventions that respond to lapses in adherence, ensuring patients remain actively involved in their recovery journey.</p>
<p>Furthermore, the Bergen 4-day format itself may inherently bolster adherence by virtue of its intensity and immersive nature. The condensed timeframe requires patients to commit fully, potentially creating a therapeutic environment rich in accountability and focus. This intensive exposure could help bypass some of the motivational volatility seen in traditional, longer-duration treatments, making it a promising option for difficult-to-treat cases.</p>
<p>Importantly, this study also highlights the role of self-reporting as a tool in measuring adherence and engagement. While self-rated scales like PEAS provide valuable insights, there is room to explore integrating objective monitoring technologies in future research. Wearable devices, mobile apps, and passive data collection could enhance the precision and reliability of adherence assessment, tailoring interventions in real-time to patient needs.</p>
<p>The research, registered under ClinicalTrials.gov identifier NCT02656342, marks a significant step forward in understanding the complexities of motivation within intensive therapeutic frameworks. By disentangling motivation from adherence and highlighting the prominence of the latter, it opens up new pathways for optimizing treatment delivery and improving outcomes for patients who have historically struggled to find relief.</p>
<p>In summary, this study challenges the clinical community to rethink motivational assessments for OCD treatment. It advocates prioritizing ongoing patient adherence and real-time engagement as critical factors influencing recovery, particularly within intensive treatment models like the Bergen 4-day program. As OCD continues to affect millions worldwide, insights such as these are pivotal in refining therapeutic approaches and enhancing the lives of those affected by this challenging disorder.</p>
<p>The Bergen 4-day treatment research exemplifies how blending clinical rigor with innovative treatment formats and nuanced motivational assessment can create a new frontier in mental health care. Patients, clinicians, and the scientific community alike stand to benefit from these advances, which promise higher remission rates and a clearer understanding of what drives effective long-term OCD management.</p>
<hr />
<p><strong>Subject of Research</strong>: Motivation, patient adherence, and treatment outcomes in the Bergen 4-day treatment for difficult-to-treat obsessive–compulsive disorder (OCD).</p>
<p><strong>Article Title</strong>: Motivation in the Bergen 4-day treatment for obsessive–compulsive disorder</p>
<p><strong>Article References</strong>:<br />
Berg, H., Tjelle, K., Solem, S. <em>et al.</em> Motivation in the Bergen 4-day treatment for obsessive–compulsive disorder. <em>BMC Psychiatry</em> 25, 958 (2025). <a href="https://doi.org/10.1186/s12888-025-07218-z">https://doi.org/10.1186/s12888-025-07218-z</a></p>
<p><strong>Image Credits</strong>: AI Generated</p>
<p><strong>DOI</strong>: <a href="https://doi.org/10.1186/s12888-025-07218-z">https://doi.org/10.1186/s12888-025-07218-z</a></p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">88422</post-id>	</item>
		<item>
		<title>Boosting Adolescent Engagement in Eating Disorder Treatment</title>
		<link>https://scienmag.com/boosting-adolescent-engagement-in-eating-disorder-treatment/</link>
		
		<dc:creator><![CDATA[SCIENMAG]]></dc:creator>
		<pubDate>Wed, 03 Sep 2025 17:27:22 +0000</pubDate>
				<category><![CDATA[Medicine]]></category>
		<category><![CDATA[adolescent eating disorder treatment strategies]]></category>
		<category><![CDATA[building trust with adolescent patients]]></category>
		<category><![CDATA[challenges in eating disorder treatment]]></category>
		<category><![CDATA[clinical approaches for adolescent mental health]]></category>
		<category><![CDATA[cognitive behavior therapy for teens]]></category>
		<category><![CDATA[developmental needs of adolescents]]></category>
		<category><![CDATA[engaging adolescents in therapy]]></category>
		<category><![CDATA[enhancing treatment outcomes for teenagers]]></category>
		<category><![CDATA[innovative approaches to therapy]]></category>
		<category><![CDATA[patient engagement in mental health]]></category>
		<category><![CDATA[psychological well-being in adolescents]]></category>
		<category><![CDATA[relational dimensions in therapy]]></category>
		<guid isPermaLink="false">https://scienmag.com/boosting-adolescent-engagement-in-eating-disorder-treatment/</guid>

					<description><![CDATA[The treatment of eating disorders in adolescents is a complex yet critical area of mental health that demands a comprehensive understanding of patient engagement. Recent research conducted by leading experts in the field, Dalle Grave and Calugi, focuses on innovative strategies within enhanced cognitive behavior therapy (CBT) to connect with adolescent patients. This exploration into [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>The treatment of eating disorders in adolescents is a complex yet critical area of mental health that demands a comprehensive understanding of patient engagement. Recent research conducted by leading experts in the field, Dalle Grave and Calugi, focuses on innovative strategies within enhanced cognitive behavior therapy (CBT) to connect with adolescent patients. This exploration into adolescent treatment forms a significant contribution to psychological well-being, illustrating not only the challenges faced but also potential paths toward effectiveness.</p>
<p>Engaging with adolescent patients can often be a double-edged sword; while they exhibit an array of behavioral and emotional challenges, they also offer unique perspectives and insights that can enhance treatment outcomes. The study emphasizes the importance of building alliances and trust between therapists and teenagers dealing with eating disorders. Adolescence represents a crucial transitional period characterized by heightened psychological sensitivity and fluctuating self-identity. Thus, professionals in the field must adapt their clinical approaches to suit these dynamic changes.</p>
<p>Central to the findings is the premise that enhanced cognitive behavior therapy can specifically address the distinct needs of adolescents. Traditional approaches may overlook the experiential and relational dimensions that are pivotal for this age group. By incorporating developmentally tailored strategies, therapists can offer a more engaging and personalized treatment experience which can lead to improved adherence and outcomes. These modifications stem from understanding how adolescents perceive their conditions and the importance they place on peer relationships and social dynamics.</p>
<p>One of the strategies proposed in this research includes the integration of motivational interviewing techniques to pique the interest and involvement of young patients. This person-centered approach emphasizes the development of intrinsic motivation and allows adolescents to voice their desires and concerns. By doing so, therapists create a collaborative environment that helps the young patients feel valued and understood. This validation is particularly important in therapeutic settings, as it fosters openness and honesty in sharing sensitive information.</p>
<p>Another critical element highlighted in the study is the incorporation of technology into treatment. Digital interventions can extend the boundaries of traditional therapy and offer adolescents interactive and flexible options for engagement. Tools such as mobile applications provide immediate access to therapeutic resources and foster real-time communication between patients and their care providers. This modern approach not only meets adolescents where they are—in their digital landscapes—but also empowers them to take a more active role in their recovery journey.</p>
<p>Therapists are also encouraged to utilize creative therapeutic techniques, such as art and narrative therapy, to enhance engagement. These methods encourage self-expression and provide adolescents with alternative avenues to articulate their feelings and struggles with eating disorders. Introducing artistic modalities can significantly diminish the pressure often felt in verbal communication, thereby creating a more comfortable atmosphere for self-discovery and reflection.</p>
<p>The involvement of family in the treatment process is another fundamental aspect underscored in this research. Training families to understand the nuances of eating disorders allows them to become incorporation allies in their adolescent&#8217;s therapeutic journey. Engaging caregivers narrows the gap between adolescent experiences and family perceptions, fostering an environment where open communication thrives. By establishing a unified front, families can support their loved ones’ challenges while reinforcing positive changes.</p>
<p>Moreover, the study emphasizes the importance of cultural competency in therapy. Adolescent patients come from diverse backgrounds, each stamped with varying beliefs, values, and experiences that shape their relationship with eating and body image. A culturally sensitive approach ensures that treatment methodologies are respectful and responsive to these differences. Adhering to this principle allows for a more inclusive understanding of and approaches to eating disorders while better meeting the individual needs of each adolescent patient.</p>
<p>Dalle Grave and Calugi&#8217;s study further identifies the significance of feedback loops in treatment to monitor progress and maintain engagement. Continuous evaluation and adaptation of the therapeutic process based on patient feedback can enhance motivation and accountability. This adaptive style of therapy not only provides direction but also reaffirms patient agency, which is especially vital for adolescents striving to navigate their environments and cope with their disorders.</p>
<p>The establishment of support networks also plays a large role in the findings presented by the researchers. Creating spaces where adolescents can connect with their peers facing similar challenges fosters a sense of belonging and reduces feelings of isolation. Group therapy sessions can offer profound insights and encouragement, allowing participants to share successes and setbacks. The shared experience validates individual struggles while emphasizing collective growth.</p>
<p>Furthermore, an emphasis on psychoeducation is necessary to provide adolescent patients with comprehensive knowledge about their disorders. Understanding the biological, psychological, and sociocultural factors contributing to eating disorders can demystify the experience for these young patients. Equipping adolescents with this knowledge enables them to make informed decisions about their treatment, further enhancing engagement.</p>
<p>The potential for long-term success also rests on the maintenance of coping strategies learned during therapy. Encouraging adolescents to practice these strategies in real-world scenarios bridges the gap between therapy and everyday life, ensuring that skills are not only practiced but ingrained in their daily routines. This practical application is where the theory of enhanced cognitive behavioral therapy comes full circle; it transforms theoretical knowledge into sustained lifestyle changes.</p>
<p>Crucially, the researchers assert that societal attitudes toward mental health and eating disorders need to evolve. Stigmatization can lead to reluctance in seeking help among adolescents. Public awareness campaigns focusing on destigmatization and education surrounding eating disorders can pave the way for more open conversations and greater acceptance, thereby lowering barriers to treatment.</p>
<p>In summation, the findings from Dalle Grave and Calugi offer substantial guidance in treating eating disorders among adolescents through enhanced cognitive behavior therapy. The study provides a roadmap for mental health professionals navigating the intricate landscape of adolescent psychology, emphasizing the importance of patient engagement, the role of family, and the application of modern technology in therapeutic practices. As society continues to grapple with the complexities of mental health, embracing these strategies presents a promising pathway to fostering better outcomes for young patients battling eating disorders.</p>
<hr />
<p><strong>Subject of Research</strong>: Engagement of adolescent patients in the treatment of eating disorders.</p>
<p><strong>Article Title</strong>: Engaging the adolescent patients in the treatment of eating disorders: strategies and procedures of enhanced cognitive behavior therapy.</p>
<p><strong>Article References</strong>:</p>
<p class="c-bibliographic-information__citation">Dalle Grave, R., Calugi, S. Engaging the adolescent patients in the treatment of eating disorders: strategies and procedures of enhanced cognitive behavior therapy.<br />
                    <i>J Eat Disord</i> <b>13</b>, 199 (2025). https://doi.org/10.1186/s40337-025-01390-z</p>
<p><strong>Image Credits</strong>: AI Generated</p>
<p><strong>DOI</strong>: 10.1186/s40337-025-01390-z</p>
<p><strong>Keywords</strong>: Eating disorders, adolescent treatment, cognitive behavior therapy, patient engagement, mental health.</p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">75053</post-id>	</item>
		<item>
		<title>Incentives Boost Long-Acting Antipsychotic Use</title>
		<link>https://scienmag.com/incentives-boost-long-acting-antipsychotic-use/</link>
		
		<dc:creator><![CDATA[SCIENMAG]]></dc:creator>
		<pubDate>Mon, 18 Aug 2025 08:39:34 +0000</pubDate>
				<category><![CDATA[Psychology & Psychiatry]]></category>
		<category><![CDATA[antipsychotic medication adherence]]></category>
		<category><![CDATA[community mental health professionals]]></category>
		<category><![CDATA[ethical considerations in healthcare incentives]]></category>
		<category><![CDATA[financial incentives in healthcare]]></category>
		<category><![CDATA[healthcare cost-benefit analysis]]></category>
		<category><![CDATA[LAI antipsychotic administration]]></category>
		<category><![CDATA[long-acting injectable antipsychotics]]></category>
		<category><![CDATA[mental health treatment innovations]]></category>
		<category><![CDATA[patient engagement in mental health]]></category>
		<category><![CDATA[psychiatric care challenges]]></category>
		<category><![CDATA[qualitative research in psychiatry]]></category>
		<category><![CDATA[relapse prevention strategies]]></category>
		<guid isPermaLink="false">https://scienmag.com/incentives-boost-long-acting-antipsychotic-use/</guid>

					<description><![CDATA[In recent years, the challenge of ensuring consistent adherence to antipsychotic medication among patients with serious mental illness has remained a significant obstacle in psychiatric care. Long-acting injectable (LAI) antipsychotics have emerged as a valuable intervention to reduce relapse and hospital readmission rates, particularly for patients who struggle with daily oral medication regimens. Despite their [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>In recent years, the challenge of ensuring consistent adherence to antipsychotic medication among patients with serious mental illness has remained a significant obstacle in psychiatric care. Long-acting injectable (LAI) antipsychotics have emerged as a valuable intervention to reduce relapse and hospital readmission rates, particularly for patients who struggle with daily oral medication regimens. Despite their clinical benefits, engagement with LAIs is often suboptimal, raising concerns among mental health professionals and researchers alike. A groundbreaking study published in <em>BMC Psychiatry</em> now sheds light on an innovative approach to enhancing adherence: the use of financial incentives.</p>
<p>This new research offers a nuanced exploration of community mental health professionals’ perspectives on financial incentives as a strategy to promote consistent use of LAI antipsychotics. Traditionally, financial incentives in healthcare have sparked debate around ethics and long-term effectiveness. However, this study ventures beyond mere cost-benefit analysis by integrating qualitative insights from frontline clinicians who directly administer these treatments. Their views provide critical context for understanding the practical potential and pitfalls of such schemes.</p>
<p>The study’s methodology involved in-depth interviews with fourteen mental health professionals specializing in LAI administration. Through a snowball recruitment process, these participants were selected for their expertise and direct patient contact. Initially, participants shared their unconditioned thoughts on financial incentives. Subsequently, they reviewed a concise presentation summarizing the latest empirical evidence demonstrating the positive impact incentives can have on engagement rates, particularly among individuals at the highest risk of relapse. This two-stage interview process allowed researchers to capture shifts in attitudes informed by evidence exposure.</p>
<p>Upon reflection, the researchers discovered a measurable increase in support for financial incentives, with self-reported endorsement ratings climbing from a median score of 5 out of 10 to nearly 7 after participants reviewed the empirical data. This change underscores the importance of evidence dissemination within clinical communities, suggesting that skepticism may be tempered by exposure to robust research outcomes. Practitioners began to conceptualize financial incentives not as coercion but as a form of positive reinforcement — essentially, a ‘reward’ system that could dovetail with therapeutic goals.</p>
<p>Importantly, the interviewed professionals connected the potential benefits of incentives to broader clinical outcomes beyond mere medication adherence. They speculated that increased engagement could foster greater patient insight into illness management, enhancing self-efficacy and therapeutic relationships. These improvements could subsequently contribute to a virtuous cycle, where patients become more active participants in their own care, potentially mitigating the repeated cycles of relapse that often characterize psychiatric disorders.</p>
<p>Nevertheless, the study does not shy away from detailing the complexities and ambivalence surrounding financial incentives. Several mental health professionals expressed concern about unintended consequences, chiefly the possibility that incentives might encourage superficial compliance without genuine clinical improvement. A particular worry was that some patients might misuse the funds, potentially increasing substance use or other maladaptive behaviors. These ethical quandaries highlight the need for carefully designed incentive programs that prioritize patient safety and holistic well-being.</p>
<p>Additionally, participants envisioned numerous implementation challenges, such as administrative burdens, resource allocation, and the delicate balance between extrinsic motivators and intrinsic motivation for treatment. They emphasized that the success of financial incentive programs depends heavily on thoughtful integration within existing clinical structures and ongoing evaluation mechanisms. Some proposed potential solutions, including tiered incentive schemes that account for individual patient needs and structured oversight to minimize risks.</p>
<p>Crucially, the researchers advocate for a broader dialogue among stakeholders — patients, clinicians, policymakers — to develop incentive frameworks that align with diverse preferences and cultural contexts. The study suggests that future investigations should extend beyond professional opinions to directly measure patient perspectives on receiving financial incentives for medication adherence, thus allowing for more patient-centered program design. This participatory approach could enhance acceptability, efficacy, and ethical grounding.</p>
<p>While previous literature has largely focused on quantitative outcomes of financial incentives, this study’s qualitative approach illuminates the lived experiences and professional judgments that often shape clinical decision-making. By making the concerns and hopes of mental health practitioners explicit, the research invites a more comprehensive consideration of how best to harness behavioral economics in psychiatric care.</p>
<p>The use of financial incentives to improve engaged care reflects a broader trend toward integrating behavioral intervention strategies within mental health treatment plans. As psychiatric services grapple with systemic challenges such as limited resources and high rates of treatment dropout, novel strategies that incentivize adherence offer a promising, if complex, avenue worth pursuing. This study’s findings generate an important foundation for evidence-based policy initiatives seeking to optimize therapeutic outcomes.</p>
<p>In conclusion, the analysis confirms that mental health professionals are not monolithic in their views on financial incentives for LAI antipsychotic adherence. While initial skepticism exists, exposure to empirical research fosters more favorable attitudes and openness to innovative approaches. This evolution signals a potential paradigm shift in managing psychotic disorders, where financial incentives could play a complementary role alongside pharmacological and psychosocial interventions.</p>
<p>Moving forward, it is imperative that multidisciplinary research continues to unravel the optimal design and implementation of incentive schemes, taking into account ethical, operational, and clinical dimensions. This study lights a path toward more collaborative, transparent conversations that center the well-being of patients while leveraging the insights of healthcare providers. As the mental health field embraces such integrated strategies, it holds promise for substantially improving the lives of individuals living with chronic psychiatric conditions.</p>
<hr />
<p><strong>Subject of Research</strong>: The acceptability and perceived utility of financial incentives by community mental health professionals to improve engagement with long-acting injectable antipsychotics in patients at risk of relapse.</p>
<p><strong>Article Title</strong>: Financial incentives and long-acting injectable antipsychotics engagement: community mental health professionals’ perspectives</p>
<p><strong>Article References</strong>:<br />
Hodson, N., Majid, M., Vlaev, I. <em>et al.</em> Financial incentives and long-acting injectable antipsychotics engagement: community mental health professionals’ perspectives. <em>BMC Psychiatry</em> <strong>25</strong>, 791 (2025). <a href="https://doi.org/10.1186/s12888-025-07165-9">https://doi.org/10.1186/s12888-025-07165-9</a></p>
<p><strong>Image Credits</strong>: AI Generated</p>
<p><strong>DOI</strong>: <a href="https://doi.org/10.1186/s12888-025-07165-9">https://doi.org/10.1186/s12888-025-07165-9</a></p>
]]></content:encoded>
					
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">66096</post-id>	</item>
	</channel>
</rss>
